Fig. 3.
Therapeutic development funnel designed to identify neuroprotective and regenerative agents for use against diabetic neuropathy. Progression of guaifenesin and M1 receptor (M1R) antagonists through the funnel is indicated by arrows.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.